US Patent 11084852 Ubiquitin interacting motif peptides as therapeutics
Patent 11084852 was granted and assigned to Oklahoma Medical Research Foundation on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+221 characters)
Article
Patent abstract
The present disclosure describes the use peptides of comprising ubiquitin interacting motifs (UIMs) alone or in combination with other agents to treat conditions such as cancer, atherosclerosis and obesity.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Hong Chen0
Yunzhou Dong0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110848520
Date of Patent
August 10, 2021
0Patent Application Number
201606080
Date Filed
June 8, 2016
0Official Website
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Oct, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11084852 Ubiquitin interacting motif peptides as therapeutics
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11084852
Date of patent
August 10, 2021
Patent application number
20160608
Date Filed
June 8, 2016
Find more entities like US Patent 11084852 Ubiquitin interacting motif peptides as therapeutics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
